Muhlenkamp & Co’s CVS Health CVS Stock Holding History

Muhlenkamp & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-110,695	Closed	-$7.65M	–	32
2023 Q2	$7.65M	Buy	+110,695	New	+$7.88M	2.71%	18
2022 Q4	$10.3M	Buy	110,123 +122	+0.1%	+$11.8K	4.35%	13
2022 Q3	$10.5M	Buy	110,001 +1,078	+1%	+$107K	4.68%	8
2022 Q2	$10.1M	Sell	108,923 -114	-0.1%	-$11.1K	4.73%	9
2022 Q1	$11M	Buy	109,037 +404	+0.4%	+$42.4K	3.84%	11
2021 Q4	$11.2M	Sell	108,633 -12	-0%	-$1.11K	3.91%	12
2021 Q3	$9.22M	Sell	108,645 -189	-0.2%	-$15.8K	3.54%	15
2021 Q2	$9.08M	Buy	108,834 +189	+0.2%	+$15.5K	3.33%	18
2021 Q1	$9.39M	Buy	108,645 +334	+0.3%	+$24.3K	3.48%	14
2020 Q4	$7.4M	Buy	108,311 +852	+0.8%	+$55.4K	2.98%	19
2020 Q3	$6.28M	Buy	107,459 +911	+0.9%	+$56.7K	3.25%	17
2020 Q2	$6.92M	Buy	+106,548	New	+$6.71M	3.7%	12
2019 Q4	$7.91M	Buy	106,514 +36,479	+52%	+$2.56M	3.46%	10
2019 Q3	$4.42M	Buy	+70,035	New	+$4.15M	2.15%	23

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Muhlenkamp & Co's CVS Position: Q3 2023 in Review

Muhlenkamp & Co sold out of CVS Health (CVS) in Q3 2023, closing a stake of 110,695 shares — an estimated $7.65M sold.

Muhlenkamp & Co first reported a position in CVS in Q3 2019 and held it in 14 quarters. The position peaked at $11.2M in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Muhlenkamp & Co reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Muhlenkamp & Co sold 110,695 CVS Health shares in Q3 2023, an estimated $7.65M.
Muhlenkamp & Co first reported a position in CVS Health in Q3 2019 and held it in 14 quarters.
Muhlenkamp & Co's CVS Health position peaked at $11.2M in Q4 2021.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Muhlenkamp & Co's 13F filing for Q3 2023, filed 6 Dec 2023.